We represented MRI Interventions, Inc. in a $7.522 million private placement of shares of common stock. The 2,426,455 shares of MRI Interventions’ common stock were sold at a negotiated price of $3.10 per share. The proceeds of the offering are expected to be used primarily for working capital and general corporate purposes. Additionally, we advised MRI Interventions in its uplisting to NYSE American. The uplisting is effective for trading on July 3, 2019, and MRI Intervention’s common stock will trade under its existing stock symbol, “MRIC.”

As of February 2020, MRI was rebranded as ClearPoint Neuro, Inc. trading on the Nasdaq as CLPT.